Inomax and disseminated intravascular coagulation Patient Reports February 13, 2012
Inomax Side Effects Report #5093107-X
Inomax side effect was reported by a Consumer or non-health professional from BELGIUM on Aug 23, 2006. Female patient was diagnosed with prophylaxis, respiratory disorder and was treated with Inomax. After drug was administered, patient experienced the following side effects: candida sepsis, capillary leak syndrome, cardiovascular disorder, dilatation ventricular, disseminated intravascular coagulation, inflammation, intestinal perforation, intraventricular haemorrhage neonatal. Inomax dosage: unknown. During the same period patient was treated with CAFFEINE, MICONAZOLE, VANCOMYCIN, CEFOTAXIME, METRONIDAZOLE, FENTANYL, INSULIN. Patient was hospitalized. Patient died.
Inomax Side Effects Report #5942701-X
Inomax side effect was reported by a Health Professional from UNITED STATES on Oct 22, 2008. Male patient was diagnosed with neonatal respiratory distress syndrome, persistent foetal circulation and was treated with Inomax. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, heart rate decreased, intestinal perforation, neonatal disorder, oxygen saturation decreased. Inomax dosage: unknown. Patient died on 10/22/2008.
Inomax Side Effects Report #5960942-2
Inomax side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2008. Male patient was diagnosed with neonatal respiratory distress syndrome, persistent foetal circulation and was treated with Inomax. After drug was administered, patient experienced the following side effects: device malfunction, disseminated intravascular coagulation, heart rate decreased, intestinal perforation. Inomax dosage: unknown. Patient died on 10/22/2008.
Inomax Side Effects Report #5054085-2
Inomax side effect was reported by a Consumer or non-health professional from BELGIUM on July 11, 2006. Female patient was diagnosed with lung disorder, prophylaxis and was treated with Inomax. After drug was administered, patient experienced the following side effects: candida sepsis, capillary leak syndrome, cerebral ventricle dilatation, disseminated intravascular coagulation, hypoxia, intestinal perforation, intraventricular haemorrhage neonatal, neonatal disorder, neonatal hypotension. Inomax dosage: unknown. During the same period patient was treated with CAFFEINE, MICONAZOLE, VANCOMYCIN, CEFOTAXIME, METRONIDAZOLE, FENTANYL, INSULIN. Patient was hospitalized. Patient died.
Inomax Side Effects Report #4931236-9
Inomax side effect was reported by a Consumer or non-health professional from SPAIN on Feb 16, 2006. Male patient was diagnosed with lung disorder, prophylaxis and was treated with Inomax. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, klebsiella infection, platelet count decreased, prothrombin time prolonged, sepsis neonatal, skin discolouration, white blood cell count decreased. Inomax dosage: unknown. During the same period patient was treated with CEFOTAXIME, VANCOMYCIN, DOMPERIDONE, TOBRAMYCIN, RANITIDINE, FENTANYL, INSULIN. Patient recovered.
Inomax Side Effects Report #4940734-3
Inomax side effect was reported by a Consumer or non-health professional from SPAIN on Feb 27, 2006. Male patient was diagnosed with lung disorder, prophylaxis and was treated with Inomax. After drug was administered, patient experienced the following side effects: anaemia neonatal, disseminated intravascular coagulation, hyperglycaemia, klebsiella infection, neonatal disorder, peritoneal dialysis, sepsis neonatal, shock. Inomax dosage: unknown. During the same period patient was treated with NITRIC OXIDE, CEFOTAXIME, VANCOMYCIN, DOMPERIDONE, TOBRAMYCIN, RANITIDINE, FENTANYL. Patient died.
Inomax and disseminated intravascular coagulation 